Previous 10 | Next 10 |
Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference PR Newswire CAMBRIDGE, Mass. , May 19, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of pe...
Akebia Therapeutics (NASDAQ:AKBA) has lost ~18% in the pre-market Monday after the Cambridge, Massachusetts-based biotech announced that the Japanese drugmaker Otsuka Pharmaceutical plans to end its partnership for the development of kidney disease therapy, vadadustat. According to ...
Buying Penny Stocks on May 11th? Here’s What You Need to Know With another day of trading penny stocks and blue chips done, there is a lot for investors to consider. As we enter more selling off in the stock market, most traders are fearful right now about what the future could h...
Akebia Therapeutics, Inc. (AKBA) Q1 2022 Earnings Conference Call May 09, 2022, 16:30 ET Company Participants Mercedes Carrasco - Director, Corporate Communications John Butler - CEO, President & Director David Spellman - SVP, CFO & Treasurer Conference Call Participants Allison Bratz...
New York, New York--(Newsfile Corp. - May 9, 2022) - Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the "Company") (NASDAQ: AKBA) of a class action securities lawsuit. The lawsuit on behalf of Akebia investors has been commenced in the the United Stat...
Akebia press release (NASDAQ:AKBA): Q1 GAAP EPS of -$0.35 misses by $0.06. Revenue of $61.7M (+18.0% Y/Y) beats by $17.48M. 2022 Net Auryxia product revenue guidance of $165 - $170M Outlines refined strategic focus to deliver shareholder value. Shares +9.76%. For further details see: Ak...
Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update PR Newswire Net Auryxia ® (ferric citrate) product revenue of $41.4M , a 36% increase over Q1 2021 2022 Net Auryxia product revenue guidance of $165 - $170M ...
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT, CAPL, CARA, CARG, CHMI, CLAR, CLOV, CNNE, CSTL, OTCPK:CURLF, DDD, DHT, DNB, ENTA, EQH, EVBG, FCRD, FF, FGEN, FLL, ...
Akebia Therapeutics to Report First Quarter Financial Results PR Newswire Akebia to Host Conference Call to Provide Business Update CAMBRIDGE, Mass. , May 2, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical compan...
You can make money with penny stocks if you know how to trade. Sure, some might get lucky here and there, catching a big breakout. However, in general, even when you’re looking at stocks under $1, you can consistently profit. You just need to know how to handle volatility and risk. I...
News, Short Squeeze, Breakout and More Instantly...
Akebia Therapeutics Inc. Company Name:
AKBA Stock Symbol:
NASDAQ Market:
Akebia Therapeutics Inc. Website:
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets PR Newswire Akebia regains full rights to sell Vafseo® (vadadustat) Tablets in the U.S. following the execution of a royalty-based termination agreement wit...
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with t...